Try our Advanced Search for more refined results

Expert Analysis

DC Circ. Adds Feather To DEA's Regulatory Authority Hat

By Mike Gill and Jerry Canaan (July 10, 2017, 12:15 PM EDT) -- On June 30, 2017, the D.C. Circuit upheld the U.S. Drug Enforcement Administration's authority to take prescription drug suppliers to task for failing to proactively investigate, stop and report drug diversion activities. The 38-page decision in Masters Pharmaceutical, Inc. v. Drug Enforcement Administration[1] marks a significant benchmark for the DEA's diversion control authority and falls in line with the agency's continued push to require the registrant community to step up its efforts under existing regulations to protect against illegal drug diversion....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!